Press release
Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports.
Epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson's disease are the most common neurological disorder, which affect the central and peripheral nervous system. These neurological disorders are caused by genetic disorders, congenital abnormalities or disorders, infections, lifestyle or environmental health problems, including malnutrition, and brain injury, spinal cord injury or nerve injury. Bacterial, viral, and fungal infections also responsible for neurological disorders.
Get a Free sample: https://reports.valuates.com/request/sample/ALLI-Auto-4T60/Neuromodulation_Market_by_Technology_Deep_Brain_Stimulation_Sacral_Nerve_Stimulation_Vagus_Nerve_Stimulation_Spinal_Cord_Stimulation_Application_Chronic_Pain_Management_Failed_back_syndrome_Epilepsy_Tremor_Incontinence_Depression_Dystonia_Gastroparesis_Parkinsons_disease_Obsessive_Compulsive_Disorder_Migraine_and_Biomaterial_Metallic_Polymeric_Ceramic_Global_Opportunity_Analysis_and_Industry_Forecast_2014_2022
The increase in prevalence of neurological diseases globally drives the growth of the neuromodulation market. For instance, according to the Epilepsy Action organization, which is the British charity providing information for population with epilepsy, in February 2022, around 600,000 population are diagnosed with epilepsy, in UK, which is around one in every 100 population. In addition, increase in geriatric population propels the growth of neuromodulation market. The increase in R&D activities in the pharmaceutical sector and rise in number of clinical trials in the neuromodulation devices by manufacturers and researchers also contribute in the growth of market. Furthermore, surge in awareness for use of neuromodulation devices further boosts the market growth. The rise in number of hospitals and well-developed healthcare infrastructure further contributes in market growth.
In addition, increase in advancement in technology for neuromodulation devices and rise in product launch in the field of neuromodulation devices contribute in the growth of the neuromodulation market. However, the high cost of neuromodulation devices are expected to limit the growth of market.
Global Neuromodulation Market Segmentation
The neuromodulation market is segmented on the basis of technology, application, biomaterial, and region. By technology, the market is mainly categorized into internal neuromodulation and external neuromodulation. By application, it is categorized in chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson disease, epilepsy, tremor, depression, and other applications. On the basis of biomaterial, it is divided into, metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Abbott, Aleva, Neurotherapeutics SA., Boston Scientific Corporation, LivaNova, Medtronic, MicroTransponder, Neuronetics, NeuroPace Inc., NeuroSigma, and Nevro Corporation.
View full Report:https://reports.valuates.com/market-reports/ALLI-Auto-4T60/neuromodulation
KEY BENEFITS FOR STAKEHOLDERS
• The report provides an in-depth analysis of the global neuromodulation market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global neuromodulation market growth.
Neuromodulation Market Segmentation
By Technology
• Internal Neuromodulation
• External Neuromodulation
By Application
• Chronic Pain
• Urinary And Fecal Incontinence
• Migraine
• Failed Back Syndrome
• Parkinson Disease
• Epilepsy
• Tremor
• Depression
• Other Applications
By Biomaterial
• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramic Biomaterials
By Region
• North America
• Europe
• Asia-Pacific
• LAMEA
Key Market Players
• LivaNova PLC
• Nevro Corporation
• Medtronic
• NeuroSigma
• Neuronetics
• Bioventus Inc.
• NeuroPace Inc
• MicroTransponder
• MicroTransponder
• Boston Scientific Corporation
• Abbot
Inquire For Regional Reports: https://reports.valuates.com/request/regional/ALLI-Auto-4T60/Neuromodulation_Market_by_Technology_Deep_Brain_Stimulation_Sacral_Nerve_Stimulation_Vagus_Nerve_Stimulation_Spinal_Cord_Stimulation_Application_Chronic_Pain_Management_Failed_back_syndrome_Epilepsy_Tremor_Incontinence_Depression_Dystonia_Gastroparesis_Parkinsons_disease_Obsessive_Compulsive_Disorder_Migraine_and_Biomaterial_Metallic_Polymeric_Ceramic_Global_Opportunity_Analysis_and_Industry_Forecast_2014_2022
Similar Reports:
1. Deep Brain Stimulation System Market : https://reports.valuates.com/market-reports/QYRE-Auto-20Y3138/global-deep-brain-stimulation-system
2. Overactive Bladder Treatment Device Market : https://reports.valuates.com/market-reports/QYRE-Auto-33P11666/global-overactive-bladder-treatment-device
3. Medical RF Lesion Generator Market: https://reports.valuates.com/market-reports/QYRE-Auto-12D11466/global-medical-rf-lesion-generator
4. Radiofrequency Ablation Instrument Market: https://reports.valuates.com/market-reports/QYRE-Auto-19O7278/global-radiofrequency-ablation-instrument
5. Pain Management RF Lesion Generator Market : https://reports.valuates.com/market-reports/QYRE-Auto-31Z11171/global-pain-management-rf-lesion-generator
Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137
Email Id:
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuromodulation market was valued at USD 2,480.2 million in 2020 and is projected to reach USD 4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 to 2030| Valuates Reports. here
News-ID: 2746866 • Views: …
More Releases from Valuates Reports
Bipolar Plates for Fuel Cells Market Share Driven by Clean Energy Initiatives an …
Bipolar Plates for Fuel Cells - Market Size
The global market for Bipolar Plates for Fuel Cells was estimated to be worth US$ 397 million in 2023 and is forecast to a readjusted size of US$ 480.3 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-9L8937/Global_Bipolar_Plates_for_Fuel_Cells_Market_Outlook_2022
Overall Market Overview:
The Bipolar Plates for Fuel Cells market is experiencing significant growth, driven by the global shift towards clean…
Magnetic Refrigeration Market Share Driven by Energy Efficiency and Environmenta …
Magnetic Refrigeration Market Size
The global market for Magnetic Refrigeration was valued at US$ 18.2 million in the year 2024 and is projected to reach a revised size of US$ 51.8 million by 2031, growing at a CAGR of 16.4% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-2D7500/Global_Magnetic_Refrigeration_Market_Insights_and_Forecast_to_2028
Overall Market Overview:
The magnetic refrigeration market is experiencing significant growth, driven by the increasing demand for energy-efficient and environmentally friendly cooling solutions. Traditional refrigeration systems often…
Hematology Analyzers & Reagents Market Share Driven by Advancements in Diagnosti …
Hematology Analyzers & Reagents Market Size
The global market for Hematology Analyzers & Reagents was valued at US$ 9208 million in the year 2024 and is projected to reach a revised size of US$ 13800 million by 2031, growing at a CAGR of 6.0% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-1X7612/Global_Hematology_Analyzers_Reagents_Market_Insights_and_Forecast_to_2028
Overall Market Overview:
The Hematology Analyzers & Reagents market is experiencing robust growth, driven by advancements in diagnostic technologies and an increasing global…
Benchtop Fluoride Ion Meters Market Share Driven by Water Quality Monitoring and …
Benchtop Fluoride Ion Meters Market
The global market for Benchtop Fluoride Ion Meters was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-34G9428/Global_Benchtop_Fluoride_Ion_Meters_Market_Insights_Forecast_to_2028
Overall Market Overview:
The Benchtop Fluoride Ion Meters market is experiencing significant growth, driven by increasing concerns over water quality and the need for precise measurement tools…
More Releases for Neuromodulation
Rising Prevalence Of Neurological Disorders Fuels Growth In The Neuromodulation …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Neuromodulation Market Size By 2025?
In the recent years, the neuromodulation market size has seen robust growth. The market, worth $6.96 billion in 2024, is anticipated to increase to $7.62 billion in 2025 - a compound annual growth rate (CAGR) of 9.5%. Factors such as…
Neuromodulation Market worth $10.4 billion by 2027
Neuromodulation Market is projected to grow from USD 6.0 billion in 2022 to USD 10.4 billion by 2027, at a CAGR of 11.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. The market is driven by government support for research on neurological disorder along with increasing prevalence of neurological disorders. Emerging economies are expected to provide lucrative growth opportunities for the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
The internal neuromodulation…
Neuromodulation Market: Charting Future Frontiers for 2030
The Neuromodulation market was valued USD 6.5 Billion in 2023 and projected to reach USD 15.3 Billion by 2030, growing at a CAGR of 13.0% during the forecast period of 2024-2030.
The Neuromodulation Market report studies the competitive environment of the Neuromodulation Market based on company profiles and their efforts to increase product value and production. The Neuromodulation Market report discusses various factors driving or restraining the market, which will help…
Incontinence Neuromodulation Market - Reclaiming Independence, Redefining Well-b …
Newark, New Castle, USA: The "Incontinence Neuromodulation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Incontinence Neuromodulation Market: https://www.growthplusreports.com/report/incontinence-neuromodulation-market/8696
This latest report researches the industry structure, sales, revenue,…
Neuromodulation Devices Market Insights, Forecast to 2030
The report extensively examines the global Neuromodulation Devices market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Neuromodulation Devices . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market…
Neuromodulation Market Outlook 2022-2028
Neurological issues are characterized as problems that influence the mind as well as the nerves tracked down all through the human body and the spinal rope. Intense spinal line injury, Alzheimer's sickness, amyotrophic horizontal sclerosis (ALS), ataxia, chime paralysis, mind cancers, cerebral aneurysm, epilepsy, and seizures are a portion of the normal neurological issues. The biochemical, underlying, or electrical irregularities in the mind, spinal line, or different nerves bring about…
